These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33377184)

  • 61. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
    Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
    J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients.
    Takeyama N; Noguchi H; Hirakawa A; Kano H; Morino K; Obata T; Sakamoto T; Tamai F; Ishikura H; Kase Y; Kobayashi M; Naka T; Takahashi Y;
    Blood Purif; 2012; 33(4):252-6. PubMed ID: 22472324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.
    Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
    Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber.
    Nakamura T; Ebihara I; Shimada N; Koide H
    Intensive Care Med; 1998 Dec; 24(12):1272-6. PubMed ID: 9885879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors.
    Cantaluppi V; Assenzio B; Pasero D; Romanazzi GM; Pacitti A; Lanfranco G; Puntorieri V; Martin EL; Mascia L; Monti G; Casella G; Segoloni GP; Camussi G; Ranieri VM
    Intensive Care Med; 2008 Sep; 34(9):1638-45. PubMed ID: 18463848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis.
    De Rosa S; Villa G; Ronco C
    Artif Organs; 2020 Feb; 44(2):184-186. PubMed ID: 31386769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion.
    Sekino M; Murakami Y; Sato S; Shintani R; Kaneko S; Iwasaki N; Araki H; Ichinomiya T; Higashijima U; Hara T
    Sci Rep; 2023 May; 13(1):7295. PubMed ID: 37147345
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis.
    Li C; Zhang J; Yang P; Wang R; Chen T; Li L
    Heliyon; 2024 Jul; 10(13):e33735. PubMed ID: 39040355
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep.
    Yamamoto H; Koizumi T; Kaneki T; Fujimoto K; Kubo K; Honda T
    J Endotoxin Res; 2002; 8(6):419-26. PubMed ID: 12542853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
    Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
    J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Direct hemoperfusion using polymyxin-B immobilized fiber for septic shock after cardiac surgery.
    Murakami M; Miyauchi Y; Nishida M; Okada H; Hamano K
    Circ J; 2009 Apr; 73(4):658-61. PubMed ID: 19246811
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
    Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
    J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Experience of direct hemoperfusion using polymyxin B-immobilized fiber on patients with endotoxin shock from urosepsis].
    Ushida H; Koizumi S; Johnin K; Katoh K; Okada Y
    Hinyokika Kiyo; 2001 May; 47(5):329-31. PubMed ID: 11433754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia.
    Peerapornratana S; Sirivongrangson P; Tungsanga S; Tiankanon K; Kulvichit W; Putcharoen O; Kellum JA; Srisawat N
    Blood Purif; 2022; 51(1):47-54. PubMed ID: 33857940
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin.
    Nakamura T; Ebihara I; Shoji H; Ushiyama C; Suzuki S; Koide H
    Inflamm Res; 1999 Apr; 48(4):171-5. PubMed ID: 10344466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endotoxin and Cytokine Sequential Hemoadsorption in Septic Shock and Multi-Organ Failure.
    Ruiz-Rodríguez JC; Chiscano-Camón L; Palmada C; Ruiz-Sanmartin A; Pérez-Carrasco M; Larrosa N; González JJ; Hernández-González M; Ferrer R
    Blood Purif; 2022; 51(7):630-633. PubMed ID: 34515070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.